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Efficient production of a mature 
and functional gamma secretase 
protease
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Michael Morici2,3, Imre Berger  4,5, Christiane Schaffitzel  4,5, Paul E. Fraser6, 
Ralph N. Martins2,3,7 & Giuseppe Verdile1,2,3
Baculoviral protein expression in insect cells has been previously used to generate large quantities of a 
protein of interest for subsequent use in biochemical and structural analyses. The MultiBac baculovirus 
protein expression system has enabled, the use of a single baculovirus to reconstitute a protein complex 
of interest, resulting in a larger protein yield. Using this system, we aimed to reconstruct the gamma 
(γ)-secretase complex, a multiprotein enzyme complex essential for the production of amyloid-β 
(Aβ) protein. A MultiBac vector containing all components of the γ-secretase complex was generated 
and expression was observed for all components. The complex was active in processing APP and 
Notch derived γ-secretase substrates and proteolysis could be inhibited with γ-secretase inhibitors, 
confirming specificity of the recombinant γ-secretase enzyme. Finally, affinity purification was used 
to purify an active recombinant γ-secretase complex. In this study we demonstrated that the MultiBac 
protein expression system can be used to generate an active γ-secretase complex and provides a new 
tool to study γ-secretase enzyme and its variants.
Multi-protein complexes have vital roles in many cellular functions1,2. One such complex is the transmembrane 
γ-secretase enzyme that is responsible for proteolytically cleaving numerous Type I transmembrane proteins2,3. 
For example, Amyloid Precursor Protein (APP) is proteolytically cleaved by γ-secretase to generate various Aβ 
peptides, some of which have been shown to accumulate in Alzheimer’s disease (AD) brains4. Amyloidogenic 
processing of APP is initiated by β-APP cleaving enzyme-1 (BACE1) that cleaves the ectodomain of APP to gen-
erate a membrane embedded APP C-terminal fragment (C99). This APP-C99 fragment is subsequently processed 
by γ-secretase to generate multiple Aβ peptides and the APP intracellular domain (AICD)5. The generation and 
accumulation of longer Aβ peptides (e.g. Aβ42) plays a key role in the events that lead to neurodegeneration in 
the AD brain6. Therefore, γ-secretase is a logical target for the development of inhibitors/modulators aimed at 
lowering Aβ production. However, the complexity of the enzyme and its ability to process many different sub-
strates have hindered targeted, therapeutic development efforts. Undesirable off-target effects related to disrup-
tion of Notch signalling are observed in animal and human trials7–10, therefore highlighting a need for a better 
understanding of γ-secretase’s structure and function.
The enzyme consists of a combination of multi-pass transmembrane proteins, Presenilin (PS1 or PS2), 
Nicastrin (NCT), Anterior Pharynx Homologue 1 (APH1a [long/short isoform] and APH1b in human and in 
addition Aph1c in mice) and Presenilin Enhancer 2 (PEN-2). Although high-resolution structural studies11–15 
have provided an insight into the process of γ-secretase assembly and activity, additional information is still 
required. An understanding of the flexible domains of γ-secretase that are responsible for recognition, selection, 
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sorting and shuttling substrate to the active site16,17 is required. Sampling of different dynamic conformations of 
γ-secretase11,13,14, will provide us with an insight into the molecular mechanism18 essential for substrate specific 
drug developmental strategies17. Furthermore, an elucidation of the substrate-γ-secretase interaction will assist in 
developing disease specific therapeutics that target APP processing in Alzheimer’s disease and Notch processing 
in certain cancers17, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalop-
athy (CADASIL)19 and acne inversa20. In addition, as the γ-secretase enzyme is involved in a large number of 
other physiological processes by virtue of its large substrate cohort2, more detailed information pertaining to this 
enzyme will enable us to better understand its molecular mechanisms in disease and physiology.
Functional, structural and molecular insights into the γ-secretase enzyme can be obtained through recon-
structing the enzyme using an appropriate expression system and generating large amounts of pure, active 
γ-secretase complex. Moreover, a robust system allows for generation of various combinations of different 
γ-secretase component isoforms/homologues. In line with the aforementioned requirements, we investigated 
the use of a multi protein baculoviral expression system to reconstitute an active γ-secretase enzyme complex. 
Baculovirus mediated recombinant protein expression in insect cells is a suitable eukaryotic system, and is espe-
cially useful in generating large amounts of proteins and protein complexes21. The flexible baculoviral capsid 
allows packaging of large heterologous genes (>20 Kb) and recombinant protein expression can range up to 50% 
of insect cell proteins21. Thus, in comparison to yeast and mammalian systems, higher expression of large pro-
teins/protein complexes is achieved. In addition, yeast and mammalian cells express endogenous γ-secretase and 
other proteases with γ-secretase like activity and γ-secretase binding proteins22. These endogenous proteins could 
potentially influence recombinant γ-secretase expression, assembly, stoichiometry and activity23,24. Additional 
benefits of the baculovirus expression system are in its ease of use, consistency in recombinant protein expression 
and adaptability to large bio-reactor scale expression setups. These characteristics make baculoviral expression an 
appealing system to reconstitute γ-secretase enzyme complex.
Previously, baculoviral expression systems have been used to express recombinant γ-secretase, either by 
expressing individual components25,26 or the whole γ-secretase complex by co-infecting insect cells with mul-
tiple baculoviruses each containing a single core-component protein25,27. However, co-infection with multi-
ple baculoviruses to reconstitute γ-secretase is technically challenging and laborious. Co-infection augments 
baculovirus mediated impairment of cellular post-translational machinery, protein degradation and results in 
poor recovery of recombinant protein28. Deleterious effects associated with co-infection makes stoichiometric 
expression of γ-secretase components rather difficult29. Therefore, baculoviral co-infection approaches do not 
seem amenable to expressing large quantities of active multiprotein complexes like γ-secretase. In contrast, the 
MultiBac baculovirus expression system, utilises a single plasmid (pFBDM) to drive near stoichiometric expres-
sion of the complex proteins, thus circumventing limitations associated with traditional baculoviral expression 
systems30,31. Additionally, MultiBac employs a recombinant baculovirus DNA with disabled viral cathepsin and 
chitinase (cysteine protease) genes30 that are involved in viral mediated cellular liquefaction32,33. This enables 
better compartmentalization and reduced viral protease mediated degradation, of recombinant proteins30. The 
multicistronic vector, pFBDM, facilitates the generation of a single recombinant baculovirus containing multiple 
expression cassettes with identical or similar efficacy promoters (baculoviral promoters of highly expressed poly-
hedron ‘polH’ and P10 proteins). This approach achieves uniform concurrent expression of multiple proteins30,31. 
In addition, the combinatorial gene assembly method employed in MultiBac, is particularly useful to generate 
variations of a γ-secretase enzyme complex (such as different subunits and isoforms, mutants etc.) and investigate 
potential protein modulators of γ-secretase activity (i.e. CD147, TMP21, Rab213,34–36).
The versatility and flexibility of the MultiBac expression system is demonstrable in its successful applica-
tion to the production of large protein complexes (including polytopic transmembrane protein complexes), the 
development of Virus-like particle (VLP) based vaccines and gene therapy vectors37–40. The MultiBac expression 
system has been used to reconstitute a 14 subunit complex, transcription factor IID41 and a bacterial translocon 
protein complex42,43. In this study, we use the MultiBac baculoviral system to reconstitute an active, multi-subunit 
transmembrane γ-secretase enzyme complex in insect cells. We also expressed an Autosomal Dominant 
Alzheimer’s Disease (ADAD) related PS1 mutant- missing exon 9 (PS1Δ9). The PS1 mutation-PS1(Δ9) is of par-
ticular interest in understanding the molecular mechanisms of γ-secretase mediated proteolysis. PS1(Δ9) does 
not need endoproteolytic activation (lacks exon 9 wherein lies the endoproteolytic site), to process γ-secretase 
substrates26,44,45.
Results
Reconstitution of γ-secretase using MultiBac baculovirus. The cloning strategy used to insert the 
γ-secretase components into the pFBDM plasmid is outlined in Fig. 1A,B, with included protein purification tags 
are shown in Fig. 1C (octa-Histidine at the C-terminus of NCT and Calmodulin Binding Protein at N-terminus 
of PEN-2) and detailed in Materials and Methods. The final recombinant plasmid, termed pFBDM-γ-secretase, 
underwent restriction digestion analysis using HinDIII (Fig. S1). DNA sequencing was used to confirm that the 
component gene inserts were incorporated into the pFBDM in the correct orientation. DH10EmBacY E. coli, was 
transformed with pFBDM constructs to generate recombinant EmBacY bacmid. The EMBacY bacmid contains 
a YFP reporter gene to monitor viral performance and expression of heterologous proteins in insect cells30. Sf9 
cells were transfected with recombinant EmBacY bacmid extracted from DH10EMBacY E. coli to generate the 
initial baculoviruses (V0). Subsequently V1 and V2 were generated and baculoviral titre was determined on V2. 
A 50 ml suspension of Sf9 cells (1 × 106 cells/ml; >90% viability), was infected with baculovirus (V2) at multi-
plicity of infection (MOI) of 1 PFU (plaque forming unit/cell). Robust YFP expression was observed at 48 hours 
post infection (HPI) (Fig. 2D compared to Fig. 2B- control EmBacY baculovirus; Fig. 2A,C are respective bright 
field images). The YFP expression plateaued over the next 48–84HPI and then declined between 84–96HPI, con-
comitant with a reduction in cell viability to ~85% (Fig. 2E). A similar expression/viability profile was obtained 
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for the PS1Δ9 baculoviruses (data not shown). The cells were harvested and whole cell lysates were prepared for 
the detection of the components of γ-secretase by immunoblotting (Fig. 3A–D) or cell membranes were pre-
pared for co-immunoprecipitation experiments to analyse the interaction between the expressed components of 
γ-secretase (Fig. 3E–H).
Immunoblotting of cell lysates from PS1(wt)-γ-secretase infected cells, showed expression of both 
PS1-holoprotein and PS1 N-terminal fragment (PS1-NTF) (~45 KDa and 28 kDa, respectively; Fig. 3B, lane 4), 
indicating that the PS1 holoprotein undergoes endoproteolytic activation in insect cells46–48. Robust expression 
of Nicastrin (Fig. 3A, lane 4), APH1aL (Fig. 3C, lane 4) and PEN-2 (Fig. 3D, lane 4) was also observed. All 
components were shown to co-immunoprecipitate with PS1 (Fig. 3E–H, lane 4), indicating interaction between 
the components29. In addition, only the mature/glycosylated form of Nicastrin (Fig. 3E, lane 4; ~110 KDa) 
co-immunoprecipitated with PS1, consistent with an intact functional complex49. Immunoblotting using the 
penta-his antibody detected the “octa-His” tag from insect cell expressing Nicastrin (Fig. 3I; lane 4) and not 
endogenous Nicastrin from human neuroblastoma SHSY5Y cells (Fig. 3I; lane 3), while the Nicastrin antibody 
Figure 1. Cloning Strategy to incorporate cDNA encoding γ-secretase components into the MultiBac pFBDM 
plasmid. PS1 and APH1aL cDNAs were cloned from pGEM®T vectors. PEN-2 and Nicastrin DNA constructs 
were cloned into the pUCS and pSPL vectors respectively. The polH and p10 annotations indicate the promoters 
of the respective baculoviral genes (A) Step 1: PS1 was cloned at multiple cloning site 1 (MCS1) of the pFBDM 
plasmid to generate pFBDM-PS1. Step 2: APH1aL was cloned into pFBDM-PS1 at the MCS2 to generate 
pFBDM-PS1-APH1aL. Step 3: PEN-2 cDNA construct was cloned at the SpeI restriction site on pFBDM-
PS1-APH1aL. Step 4: The pSPLpolH-NCT-octa-his was cloned into pFBDM-PS1-Aph1aL-Pen-2 generated 
in step 3 by Cre-lox recombination to generate pFBDM-γ-secretase (B) A map of the pFBDM-γ-secretase 
used to generate recombinant baculoviruses (C) A schematic of recombinant γ-secretase enzyme expressed 
in insect cells showing protein purification tags; PEN-2 tagged with Calmodulin Binding Protein (CBP) at the 
N-terminus (red arrowhead) and NCT expressed with an “octa-histidine tag” at the C-terminus (red circles).
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detected NCT in both the SHSY5Y (Fig. 3I; lane 1) and PS1(wt)-γ-secretase expressing insect cells (Fig. 3I; lane 2). 
Immunoblotting using the PEN-2 antibody detected insect cell expressed PEN-2-CBP at a higher molecular 
weight (Fig. 3J; lane 2; ~15 kDa) compared to SHSY5Y endogenous PEN-2 (Fig. 3J; lane 1; ~10 kDa). In accord-
ance with previous reports, the presence of these tags did not appear to alter the interaction of the components 
with PS1 or activity (see below)50–53. Deglycosylation of insect cell expressed and SHSY5Y endogenous NCT 
indicated similar partial resistance to Endoglycosidase-H (Endo-H) (Fig. 3K; lane 2 and lane 6), and high suscep-
tibility to Peptide-N-glycosidase F (PNGase-F) mediated deglycosylation (Fig. 3K; lanes 4 and 8).
Figure 2. Monitoring cell viability and YFP expression. Representative pictures of baculovirus infected Sf9 
cells viewed using bright field (A,C) or fluorescent microscopy (B,D). Sf9 cells infected with empty baculovirus 
EmBacY (A,B) or those infected with the recombinant baculovirus expressing PS1(wt)-γ-secretase (C,D). 
(E) V2 recombinant baculoviruses were used to infect Sf9 cells (1 × 106 cells/ml; ~90% viability) at MOI of 
1 PFU. Every 12 hours post infection (HPI) 1 × 106 cells were harvested, and YFP expression was monitored 
by using a plate reader at ~520 nm against a PBS blank. Relative fluorescence units were plotted against time. 
Magnification 20x, Scale Bar 100 μm.
www.nature.com/scientificreports/
5SCIENTIFIC RepoRts |  (2018) 8:12834  | DOI:10.1038/s41598-018-30788-w
Figure 3. The γ-secretase components are expressed and interact with PS1. Expression of all γ-secretase 
enzyme components was observed in whole cell lysates of insect cells infected with recombinant baculovirus 
expressing components was observed in whole cell lysates of insect cells infected with recombinant baculovirus 
expressing PS1(wt)-γ-secretase (A–D, lane 4). No such expression was observed in cells infected with control 
baculovirus EmBacY (A–D, lane 1) or recombinant baculovirus with control pFBDM plasmid (A–D, lane 2). 
Both PS1 holoprotein and PS1-NTF (antibody Ab14) were observed in insect cells infected with recombinant 
baculoviruses PS1(wt)-γ-secretase (B, lane 4); indicating successful endoproteolysis of PS1. Robust expression 
of mature (A lane 4, ~110 KDa) and minimal expression of immature (A lane 4; ~80 Kda) Nicastrin was 
observed. (E–H) Immunoprecipitation using PS1 Ab14 antibody was performed on γ-secretase expressing 
insect cell membranes. All four components of γ-secretase enzyme co-immunoprecipitated with PS1 antibody, 
indicating interaction with PS1. Only mature NCT (E lane 4; ~110 kDa) was observed to interact with PS1. 
(F) PS1 antibody NT1 was used to detect immunoprecipitated PS1. (I) Western immunoblotting of SHSY5Y 
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Immunoblotting of insect cell lysates expressing PS1(Δ9) showed expression of the PS1 holoprotein (Fig. 3B, 
lane 3). It was noted, however, that additional protein bands ranging from ~15–30 kDa were detected with the 
polyclonal PS1 N-terminal antibody, Ab14. The relevance of these additional protein bands is unclear, particularly 
following expression of the PS1(Δ9), which lacks exon 9 and thus cannot undergo endoproteolysis and thereby 
could possibly indicate nonspecific proteolysis. These lower molecular weight fragments, were absent following 
immunoprecipitation with Ab14 and immunoblotting with the monoclonal antibody NT1 (Fig. 3F, lane 3), indi-
cating that they may represent degradation fragments/non-specific artifact.
MultiBac reconstituted γ-secretase enzyme complex is active. The activity of the recombinant 
PS1(wt)-γ-secretase and PS1(Δ9) was evaluated in cell free assays. PS1(Δ9) does not require other core γ 
-secretase components to process γ-secretase substrates26,44,45. Cell free assays were prepared with both APP-C99 
or Notch-C100 substrates and the Aβ/AICD (APP intracellular domain) and NICD (Notch intracellular domain) 
proteolytic cleavage fragments were detected by immunoblotting54,55. AICD and NICD were detected in cell 
free assay reactions performed with PS1(wt)-γ-secretase containing insect cell membranes, while these prod-
ucts were absent in control cell free assays (Fig. 4A, top and bottom panels compare lanes 1 and 2, with lane 4). 
Immunoblotting using WO2 (5–8 amino acids of Aβ) detected a ~4 kDa protein that migrated at a similar size 
as synthetic Aβ peptide (Fig. 4A, middle panel, compare lane 4 with lane 5). ELISA was used to confirm/quanti-
tate Aβ40 and Aβ42 generated in cell free assays (Fig. 4D). These results indicate that the reconsituted wild-type 
γ-secretase complex is actively processing the two substrates. A dose dependent reduction in the formation of 
the AICD/Aβ and NICD fragments following treatment with the γ-secretase inhibitor, DAPT (a highly potent 
γ-secretase inhibitor with similar efficacy in blocking APP and Notch processing in in vitro cell free assays56), also 
supported the PS1(wt)-γ-secretase activity (Fig. 4B).
In contrast, when the activity of PS1(Δ9) was examined in cell free assays, four times more protein was 
required to detect AICD and NICD fragments compared to PS1(wt)-γ-secretase (Fig. 4C). In addition, the quan-
tity of Aβ generated, as determined by ELISA, in the PS1(Δ9) cell free assays was markedly reduced relative to the 
equivalent PS1(wt)-γ -secretase assays (Fig. 4D). As shown in previous studies, PS1(Δ9) also led to the produc-
tion of significantly less Aβ42 compared to Aβ4044,45. These results indicate PS1(Δ9) is less efficient in processing 
γ-secretase substrates, consistent with previous studies26,44,45,57–59.
Purification of PS1(wt)-γ-secretase. Immobilised Metal Affinity Chromatography (IMAC) and 
Calmodulin affinity (CaM) was used to purify the recombinant γ-secretase enzyme complex. A range of 
detergents (including CHAPSO, Digitonin, Brij and DDM) at optimum concentrations have been tested to 
facilitate γ-secretase activity in vivo60. Endogenous γ-secretase retains maximal activity when extracted in zwit-
terionic detergent CHAPSO60, hence initial attempts at purifying γ-secretase were undertaken using CHAPSO. 
PS1(wt)-γ-secretase expressing insect cells membranes were prepared in 1% (w/v) CHAPSO and used as is 
or diluted to 0.5% or 0.25% CHAPSO to be applied to IMAC. Using these conditions, a substantial quantity 
of protein was detected in column flow-through and in subsequent washing steps, indicating poor binding of 
γ-secretase to the TALON resin (data not shown). Similar, results were obtained using Digitonin (used at 1%, 
0.5% and 0.25%) and DDM (used at 0.05%) (data not shown). A combination of detergents was then investigated 
to improve binding of the recombinant γ-secretase to the TALON resin. Insect cell membranes were dissolved in 
1% CHAPSO-Hepes buffer and diluted to 0.08% CHAPSO and 0.08% Digitonin (12.5 fold dilution). These deter-
gents have been used at indicated concentrations to purify an intact and active γ-secretase complex61. Batch incu-
bation of solubilized membranes with the TALON-IMAC resin was found to be more appropriate for maximal 
recovery of recombinant γ-secretase complex. Immunoblotting of purification fractions showed that the majority 
of the γ-secretase components were enriched in the same elution fractions (100 mM Imidazole; Fig. 5B–E, lanes 
7, 8 and 9). Although a protein signal was observed in the diluted sample, flow-through and wash fractions, lev-
els of NCT, PS1, APH1aL and PEN-2 (Fig. 5B–E; compare lanes 1–2 with lanes 8–9), were enriched in 100 mM 
Imidazole elution fraction and absent on the recovered TALON resin (data not shown) indicating that the bound 
components were almost completely eluted. We detected γ-secretase activity and thereby generation of AICD 
from APP-C99 Flag-tagged substrate only in the 100 mM Imidazole fractions (Fig. 5 lanes 7, 8 and 9). Although, 
γ-secretase components were detected by western immunoblotting in applied diluted sample, flowthrough and 
wash fractions (Fig. 5B–E; lanes 1–3), we did not detect generation of AICD in these fractions. We believe the 
concentration of recombinant γ-secretase complex in these fractions is lower than that required to produce AICD 
detectible by western immunoblotting.
The 100 mM Imidazole eluted IMAC fractions were pooled and batch incubated with Calmodulin resin 
(CaM). The resin was then washed and bound proteins were eluted with 10 mM EGTA and concentrated with 
and PS1(wt)-γ-secretase expressing insect cells with NCT antibody (lanes 1 and 2) and penta His antibody 
(lanes 3 and 4) detected “octa-His” tag on PS1(wt)-γ-secretase only (lane 4). (J) Western immunoblotting of 
SHSY5Y and PS1(wt)-γ-secretase expressing insect cells with PEN-2 antibody detected PEN-2-CBP at a higher 
molecular weight (lane 2; ~15 kDa) due to CBP tag compared to endogenous PEN-2 (lane 1; ~10 kDa). (K) 
Deglycosylation of Nicastrin from SHSY5Y and PS1(wt)-γ-secretase expressing insect cells with Endo-H (lanes 
2 and 6) and PNGase-F (lanes 4 and 8). Nicastrin expressed in insect cells showed partial resistance to Endo-H 
(lane 6), similar to SHSY5Y endogenous Nicastrin (lane 2), indicating complex glycosylation in insect cells. 
Insect cell Nicastrin was highly susceptible to PNGase-F mediated deglycosylation (lane 8), similar to SHSY5Y 
endogenous Nicastrin (lane 4). No such deglycosylation events occurred in control experiments setup without 
Endo-H (lanes 1 and 5) and PNGase-F (lanes 3 and 7).
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a 50 kDa molecular weight cut-off centrifugal filter. Coomassie stain of SDS-PAGE gel indicated enrichment of 
γ-secretase components in the 50MWCO concentrated fraction (Fig. 5G, lane 8). Additionally, western immu-
noblotting for various γ-secretase components indicated the presence of γ-secretase components in the eluted 
10 mM EGTA fractions (Fig. 5H–K, lanes 3–7) and were enriched in 50MWCO concentrated fraction (Fig. 5H–K, 
lane 8). Protein concentration of the 50MWCO concentrated fraction was measured using a BCA protein concen-
tration estimation assay and indicated a yield of ~0.9 mg/litre (of cell culture) of purified recombinant γ-secretase 
enzyme complex.
Figure 4. MultiBac γ-secretase shows activity in cleaving APP-C99 and Notch-C100. Cell free assay using 
insect cell membranes in 0.25% CHAPSO were incubated with APP-C99-Flag (A, and B, top and middle 
panels) or Notch-C100- Flag (A and B bottom panel) substrates. AICD and NICD were detected with anti-Flag 
antibody and Aβ with WO2 antibody. (A) PS1(wt)-γ-secretase lead to formation of AICD (lane 4 top panel), 
Aβ (lane 4 middle panel, run on the same gel) and NICD (lane 4 bottom panel). (B) The activity of PS1(wt)-
γ-secretase could be inhibited by γ-secretase inhibitor DAPT in a dose dependant manner and prevented 
formation of AICD (top panel), Aβ (middle panel, run on the same gel) and NICD (bottom panel). (C) Cell 
free assay setup with PS1(Δ9) gave rise to AICD (lane 2 top panel) and NICD (lane 2 bottom panel) when used 
at 4 times the concentration of PS1(wt)-γ-secretase (lane 3). (D) Cell free assays were setup as above using cell 
membranes prepared from insect cells expressing PS1(wt)-γ-secretase or PS1(Δ9) or mammalian cells HEK293/
APPSwe or HEK293/APPSwe/PS1++ cells. The cell free assay products were analysed by sandwich ELISA. 
Baculovirally reconstituted PS1(wt)-γ-secretase produced similar levels of Aβ40 when compared to mammalian 
HEK293 cells stably expressing APPSwe (HEK293/APPSwe) and HEK293/APPSwe cells transiently 
overexpressing PS1 (HEK293/APPSwe/PS1++). However, in comparison PS1(wt)-γ-secretase generated 
significantly larger amounts of Aβ42. PS1(Δ9) generated very little Aβ40 and Aβ42.
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Cell free assays established with IMAC and CaM affinity purification fractions indicated AICD generation in 
IMAC purified fractions (100 mM Imidazole, Fig. 5F lanes 6–8). Additionally, pooled IMAC fractions supple-
mented with CaCl2 and MgOAc (Fig. 5L, lane 1), CaM affinity flowthrough (Fig. 5L, lane 2, containing unbound 
recombinant γ-secretase components) and 50MWCO concentrated 10 mM EGTA elution fraction (Fig. 5L, lane 8) 
generated AICD from APP-C99 in cell free assays.
Discussion
We have used the MultiBac baculoviral expression system to express and create an active γ-secretase enzyme 
complex, with activity comparable to γ-secretase from mammalian cells. Similar to previous studies in neuro-
blastoma and primary neuronal cells, overexpression of PS1 in HEK293/APPSwe cells led to an increase in Aβ42 
production when compared to endogenous γ-secretase activity62,63. The activity of recombinant γ-secretase in 
generating AICD and NICD was specific to γ-secretase activity and could be blocked by a γ-secretase inhibitor in 
a dose dependant manner. Moreover, the activity of the reconstituted γ-secretase enzyme was retained following 
purification. Previous studies have utilised co-infection of multiple monocistronic baculoviral vectors to reconsti-
tute γ-secretase in insect cells25,27,45. However due to differences in infectivity and protein production efficiencies 
of recombinant baculoviruses, it is often difficult and labour intensive to achieve a consistent relative equimolar 
expression form co-infected baculoviruses64,65. Importantly, co-transfection with multiple viruses reduces the 
Figure 5. Purification of baculovirally reconstituted γ-secretase enzyme complex. Cell membranes of PS1(wt)-
γ-secretase expressing insect cells were prepared in 1% CHAPSO and diluted to 0.08% CHAPSO and 0.08% 
Digitonin. (A) Coomassie stained SDS-PAGE of IMAC purified γ-secretase fractions. Membrane preparations 
(0.08% CHAPSO +0.08% digitonin in Hepes buffer; Buffer B) from baculovirally expressed γ-secretase 
following His-Tag purification. Lane 1, diluted membrane preparation sample; lane 2 Flow-through; lanes 3, 
wash fraction. Lanes 4–8, samples collected from column following elution with 5 mM Imidazole (lane 4 and 5) 
or 100 mM Imidazole (lane 6–8). All components were present in fractions eluted with 100 mM imidazole (B–
E). (F) Cell free assay to assess activity of the fractions to cleave APP-C99 substrate and generate AICD. AICD 
was only observed with in the sample eluted with 100 mM imidazole (lanes 6–8). (G–K) IMAC purified 100 mM 
imidazole factions were pooled (lane 1) supplemented with 2 mM CaCl2 and 2 mM MgOAc and applied to 
Calmodulin resin (CaM) and eluted in 3 ml each of 10 mM EGTA (lanes 3–7) in 0.5% CHAPSO Tris-Buffer 
(Buffer D). Eluted fractions were pooled and concentrated with 50 kDA filter before SDS-PAGE (G) Coomassie 
stained SDS-PAGE of CaM purified γ-secretase components detected all γ-secretase components in 50 kDa 
filter concentrated sample (lane 8). (H–K) Immunoblotting detected γ-secretase components enriched in 
concentrated fraction (lane 8). (L) Cell free assay setup with CaM purification fractions and APP-C99 detected 
AICD fragment in starting TALON purified fraction (lane 1), CaM flowthrough (lane 2) and concentrated 
elution fraction (lane 8).
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efficiency of protein production and achieving stoichiometric expression of the reconstituted proteins is diffi-
cult65–67. In this study, we have circumvented these issues, by using the MultiBac multicistronic expression system 
to reconstitute an active γ-secretase enzyme complex. Using the techniques described above we obtained a yield 
of ~0.9 mg/L of purified recombinant γ-secretase complex. This yield is ~4.5 times greater than that observed 
in a previous study (0.2 mg/ml) employing a multicistronic mammalian vector68. The MultiBac has a number 
of features that allows for higher recombinant protein yields. The MultiBac employs a recombinant baculovirus 
DNA with disabled viral cathepsin and chitinase (cysteine protease) genes30 that are involved in viral mediated 
cellular liquefaction32,33, thereby improving protein production. Disabling these genes enables better compart-
mentalisation of recombinant protein production and reduces viral protease mediated degradation of recombi-
nant proteins30. Additionally, the utility of MultiBac in studying γ-secretase is in its versatility to modular clone/
exchange additional expression cassettes (the baculovirus can accommodate large heterologous DNA cargo)69. 
Hence MultiBac can be easily modified to facilitate investigation of potential protein modulators of γ-secretase 
activity3,34–36.
The complex glycosylation of MultiBac reconstituted Nicastrin is of particular interest. The majority of 
the Nicastrin expressed using this MultiBac baculoviral expression system is the highly glycosylated and at a 
molecular weight corresponding to that observed in mammalian cells68,70. This is in contrast to other baculoviral 
expression systems employing poly-cistronic baculoviral expression vectors13,71. This observations is encouraging 
considering proper maturation/glycosylation of Nicastrin is required for γ-secretase activity49,72,73. Similar to pre-
vious studies, the recombinant Nicastrin in our study is also resistant to complete deglycosylation by Endo-H74, 
indicating higher order glycosylation. It is possible that better compartmentalisation of MultiBac infected insect 
cell secretory pathway gives an opportunity for Nicastrin to fully process to its mature form. Previous studies have 
indicated that baculoviral infection leads to an upregulation of glycosylation enzymes and ER transport proteins 
in insect cells75,76. In addition, baculoviral infection also leads to an increase in COPII coated transport vesicles 
that are involved in shuttling transmembrane proteins from ER to the cis-Golgi76. However, the effect that the het-
erologous γ-secretase components expressed in this study have on intracellular transport needs to be considered. 
Indeed, PS1 is known to be involved in intracellular APP sorting77 and is found in association with COPI and 
COPII vesicles78,79. NCT interacts with ER retrieval signal Rer1p80. Although, the Sf9 genome is still rudimen-
tary81,82, a role of Sf9 endogenous proteins transiently associating with γ-secretase and influencing intracellular 
transport/localisation cannot be discounted. Partial susceptibility to deglycosylation by EndoH enzyme indicate 
that insect cell expressed Nicastrin is at least rich in high-mannose glycosylation events. Nevertheless, mature 
mammalian Nicastrin is O-GlcNAcylated and sialylated83. The intrinsic limitation of the baculoviral/insect cell 
expression systems (and MultiBac) is in their inability to faithfully recapitulate post translational protein modifi-
cations of complex glycosylation and sialylation observed in mammalian proteins84. However, emerging baculo-
viral expression technologies now allow for expression of more mammalianised recombinant glycoproteins85–89. 
Further, the MultiBac expression system has been also optimised to produce complex N-linked glycosylated 
and galactosylated recombinant proteins86. Considering, the Nicastrin ectodomain functions to sterically hinder 
full length substrates90 from interacting with γ-secretase and glycosylation is involved in substrate selection91, it 
would be interesting to see if differential post translational modifications of Nicastrin observed in our system will 
allow substrates with longer ectodomain to interact with γ-secretase.
We have demonstrated the utility for the versatile MultiBac as an improved approach to express and recon-
stitute the γ-secretase enzyme. A recent study used a tetra-cistronic baculoviral expression vector to reconstitute 
and purify γ-secretase from insect cells13. While the yield of purified recombinant γ-secretase was not reported, 
Nicastrin was detected at a lower molecular weight (<98 kDa) than that detected in this study and previous 
studies where γ-secretase was overexpressed in mammalian cells68. Simpler Nicastrin glycosylation could fur-
ther impact expression of Nicastrin especially due to high susceptibility of nascent Nicastrin to degradation74. 
Additionally, only the mature complex glycosylated Nicastrin is associated with γ-secretase complex and is essen-
tial to reconstitute activity92.
The MultiBac expression system was also used to express the PS1(Δ9) clinical mutant in the absence of the 
other γ-secretase components. Intriguingly, and consistent with previous reports26,44,45, the mutant PS1 was found 
to be active, albeit the activity was lower than that observed for PS1(wt)-γ-secretase. It has been suggested that 
the PS1(Δ9) is constitutively active due to deletion of an “autoinhibitory domain” that blocks the catalytic site of 
Presenilins93,94 or, as Ahn et al.44 suggested, appropriate positioning of the catalytic aspartic dyad. Nevertheless, 
baculovirally expressed PS1(Δ9) led to negligible amounts of Aβ42 production when compared to Aβ40 pro-
duction, consistent with previous observations45. However, this finding is in contrast to activities of PS1(Δ9) in 
processing APP-C99 obtained by Ahn et al.44 and studies involving PS1(Δ9) expression with other γ-secretase 
components57,58. The reasons for this discrepancy are not clear. It has been suggested that γ-secretase substrates 
are first recruited by Nicastrin95,96 and interact with an exosite consisting of Nicastrin and PEN-297. The exosite is 
thought to interrogate and recruit appropriate substrates97. It could be speculated that due to missing γ-secretase 
component involved in substrate recruitment, our PS1(Δ9) construct although constitutively active is also less 
efficient. Cell free assay reactions are inherently disordered and spatial restriction of enzyme on proteolipos-
omes44 or active recruitment of substrates95,97 would enhance enzymatic activity. However, we cannot discount 
the possibility that PS1(Δ9), produces Aβ species other than Aβ40 and Aβ42.
Overall, our findings have validated the utility of the MultiBac expression system to concertedly express com-
ponents of heterologous protein complexes, such as γ-secretase. This baculoviral expression system can now be 
used as a method to further understand the functions of this important Aβ generating enzyme complex. In addi-
tion, the modular assembly employed in MultiBac would be particularly beneficial in understanding the effect 
of γ-secretase component heterogeneity on substrate specificity and the potential roles of protein modulators of 
γ-secretase activity3,34–36.
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The system can also be adapted to characterize ADAD linked PS mutations and their effects on substrate bind-
ing and cleavage, thereby contributing to resolving the dominant gain or loss of function debate98. The γ-secretase 
cleavage of APLP1, APLP2 and APP, or fragments thereof, could be compared. Chemical inhibitor/modulator 
screening, selectivity and binding sites could be explored using the MultiBac system. MultiBac has also now been 
modified to expedite highly efficient transduction of large heterologous DNA cargo in more relevant in vitro 
models such as primary neurons and in vivo studies in zebrafish embryos (MultiPrime69). With high throughput 
pipeline for screening co-expression constructs currently available99, this exciting approach provides a new tool 
for the study of γ-secretase that can be manipulated in many ways to provide significant insight into γ-secretase 
structure and activity.
Material and Methods
The MultiBac utilizes restriction enzyme digestion/ligation and ‘Cre-loxP’ site-specific recombination techniques 
(pFBDM, pUCDM and pSpl) making it more versatile. The pFBDM plasmid has two expression cassettes each 
containing multiple cloning sites (MCS 1 and MCS 2 for restriction enzyme cloning) and driven by promoters of 
baculoviral polH and p10 genes. Additionally, pFBDM backbone contains a multiplication module (containing 
unique restriction sites) and a LoxP site (for Cre-lox cloning) that facilitate modular insertion and exchange 
of expression cassettes from other vectors38–40,67. The EMBacY bacmid (contained within competent E. coli 
DH10EMBacY) has been engineered with viral cathepsin and chitinase genes disabled and a yellow fluorescent 
protein (YFP) expression cassette (under baculoviral promoter of ‘polH’ gene) allowing real-time monitoring of 
heterologous protein production. The EMBacY baculovirus DNA contains a mini-AttTn7 acceptor site to facil-
itate integration of the pFBDM plasmid (containing Tn7-R and Tn7-L donor sequences), while concomitantly 
allowing blue-white selection for detection of successful transposition30,38.
The cloning strategy for incorporating the γ-secretase components into pFBDM is shown in Fig. 1. Briefly, 
PS1 and APH1aL or PS1(Δ9) were cloned directly into the pFBDM- expression cassettes within multiple cloning 
sites- 1 and 2 (MCS1 and MCS2) respectively. PEN-2 expression cassette was modularly cloned using restriction 
digestion at the multiplication module (M) of pFBDM and NCT expression cassette was modularly cloned into 
pFBDM using Cre-Lox recombination to arrive at a single transfer vector referred to as pFBDM- γ-secretase 
containing cDNAs of the four components of γ-secretase enzyme complex.
Construction of γ-secretase component expression cassettes. The PS1(wt), PS1Δ9, APH1aL, NCT 
and PEN-2 inserts were generated from human cDNA templates by polymerase chain reaction (PCR). PCR prim-
ers were designed to incorporate unique restriction endonuclease sites (Supplementary Table 1) to facilitate clon-
ing in the subsequent steps. In addition, eight histidine repeats (octa-His tag) were cloned at the C-terminus of 
NCT and Calmodulin Binding Protein (CBP) purification tag was cloned at the N-terminus of PEN-2 to facilitate 
protein purification. The PCR amplified PS1(wt), PS1Δ9 and APH1aL inserts were cloned into pGEM®T easy 
(Promega A1360) vectors using ‘T-A’ cloning and maintained in E. coli One Shot® MAX Efficiency® DH5α™-T1R 
(Life Technologies, Australia 12297016).
The NCT-octa-His insert was cloned into pSPL vector (pSPL vector described previously38). The pSPL vector 
contains a LoxP site and baculoviral promoters of ‘p10’ and ‘polH’ genes. The p10 promoter was removed using 
PmeI and BstZ171 restriction enzymes to generate pSPL-polH vector. This linearized vector was ligated with 
NCT-octa-His PCR product to generate vector pSPLpolh-NCT-octa-His, which was maintained in One ShotTM 
PIR1 E. coli (Life Technologies, Australia C101010).
The PEN-2 insert was cloned into a modified version of previously described pUCDM vector38. This modified 
pUCDM vector contained a Calmodulin Binding Protein (CBP) and Strep Tag II protein purification tags fol-
lowed by an enterokinase protease recognition sequence at the N-terminus of MCS. PEN-2 cDNA was restriction 
cloned at NdeI and RsrII restriction sites at the MCS to generate the pUCDM-PEN-2 vector, which was main-
tained in One ShotTM PIR1 E. coli.
Generation of recombinant pFBDM plasmids. The PS1(wt) and PS1(Δ9) inserts were excised from 
their respective pGEM®T vectors and cloned independently into the MCS1 of pFBDM plasmid using BamHI and 
HinDIII restriction endonucleases. This generated pFBDM-PS1(wt) and pFBDM-PS1(Δ9) respectively.
Similarly, APH1aL insert was excised from the vector pGEMT-APH1aL and cloned directly at XhoI and KpnI 
restriction endonucleases sites within the MCS2 of the pFBDM-PS1(wt) vector resulting in pFBDM-PS1(wt)-APH1aL 
vector. pUCDM- PEN-2 expression cassette was cloned into the above vector at the SpeI restriction site within the 
multiplication module (M) of the pFBDM plasmid, to generate pFBDM-PS1(wt)-APH1aL-CBP-PEN-2. Finally, 
pSPLpolH-NCT-octa-his was integrated into the pFBDM-PS1(wt)-APH1aL-CBP-PEN-2 vector using ‘Cre-Lox’ 
recombination to generate ‘pFBDM-PS1(wt)-γ-secretase’. All pFBDM derived plasmids were maintained in DH5α 
E. coli.
Generation of recombinant MultiBac Baculovirus DNA. The recombinant pFBDM plasmids 
(pFBDM-PS1(wt)-γ-secretase and pFBDM-PS1(Δ9)) generated above were transformed into DH10EMBacY 
competent E. coli, containing the EMBacY bacmid100. The recombinant pFBDM plasmid transposes into the 
baculovirus DNA at the mini-attTn7 site, located within a LacZ gene, thereby disabling it and thus allowing for 
blue-white identification of successfully transposed colonies in presence of IPTG and BluoGal38. The colonies 
were selected in presence of gentamycin and kanamycin. This process generated two recombinant EMBacY bac-
mid containing either PS1(wt)-γ-secretase or PS1Δ9 cDNAs.
Cell Culture and Generation of initial baculovirus. Human embryonic kidney cells over expressing 
‘Swedish’ mutant of APP (HEK293/APPSwe cells) described before101,102 and human neuroblastoma SHSY5Y 
cells (ATCC, CRL2266) were cultured in DMEM (Sigma-Aldrich, UK D6546) and DMEM/F12 (Sima-Aldrich, 
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UK D6421) respectively, supplemented with 10% FBS (Interpath, France SFBSF,) at 37 °C in 5% CO2. Insect 
Sf9 cells (Invitrogen; USA 11496-015) were maintained at 27 °C in ambient air as either adherent or suspen-
sion cultures (shaking at 120 rpm) in Sf900™-II-serum free media (Invitrogen; USA 10902-096). The recombi-
nant or control (empty) EmBacY baculoviral DNAs were transfected into adherent cultures of Sf9 cells (1 × 106 
cells) using FuGENE®HD Transfection Reagent (Promega), using the manufacturer’s protocol. Initiation of YFP 
expression was taken as an indication of recombinant protein expression. The cells were monitored every 24 hours 
by bright-field microscopy to observe cell membrane disruption, indicating initial stages of viral mediated cell 
lysis. Conditioned media containing initial baculoviral particles (V0) was collected at <50% cell viability and 
used to infect fresh 10 ml Sf9 (1 × 106 cells/ml) suspension culture to generate V1. The V1 baculovirus was used 
to infect 50 ml of Sf9 culture to generate baculovirus V2. The baculovirus V2 was saved in 5 ml aliquots at 4 °C 
for short term or −80 °C long term and used to infect larger Sf9 cultures. The V2 viral titre was determined using 
the baculoQUANT titration kit (Oxford Expression Technologies, UK), in accordance with the manufacturer’s 
protocol. Briefly, recombinant baculovirus DNA was extracted from viral particles and baculoviral gene gp64 
was measured using qPCR and viral titre was estimated by plotting against a standard curve. Recombinant bac-
uloviruses were pelleted from 80 µl of conditioned media by centrifuging at 16,000 × g for 5 minutes at room 
temperature. Next, the recombinant and internal standard baculoviruses (supplied) were resuspended in 20 µl of 
lysis buffer (supplied) and lysed in a thermocycler and heating to 65 °C for 15 minutes, 96 °C for 2 minutes, 65 °C 
for 4 minutes, 96 °C for 1 minutes, 65 °C for 1 minutes, 96 °C for 30 seconds. Next, 2 µl of recombinant baculovirus 
DNA was mixed with qPCR reagent (12.5 µl) and baculoviral gp64 gene primers and probes (3 µl) (supplied) to 
a final volume of 25 µl. The qPCR reactions were carried out in triplicates for each sample in a ViiA7 Real-Time 
PCR System (Applied Biosystems). Mean Ct values of unknown samples were plotted against the standard curve 
to obtain plaque forming unit (PFU)/ml of conditioned media.
Protein expression analysis. Suspension Sf9 culture (10 ml at 1 × 106 cells/ml) were infected with V2 
at multiplicity of infection (MOI) of 1 PFU/cell. Every 12 hours post transfection; an aliquot of cell culture 
was harvested and cells were counted. Cell viability was estimated using 0.4% Trypan Blue exclusion method. 
Additionally, YFP expression was measured to estimate extent of baculoviral infection and recombinant protein 
expression. Every 12 hours 1 × 105 infected insect cells were harvested, washed and resuspended in 200 µl of PBS. 
Following brief sonication (30% amplitude for 10 seconds on ice), cell debris was removed by centrifugation at 
18,000 x g for 5 minutes at 4 °C. The supernatant was transferred to a 96 well plate and YFP was measured against 
a PBS blank in a fluorescence plate reader (excitation: 488 nm; emission: 520 nm).
Recombinant protein expression was observed by western immunoblotting of infected insect cell lysates. Cell 
lysates were prepared by homogenising cells in Nonidet P-40 cell lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 
cOmpleteTM protease inhibitor cocktail (Roche, Germany), 2 mM EDTA and 1% Nonidet P-40 detergent v/v) and 
incubating on ice, with intermittent vortexing every ten minutes, for a total time of 30 minutes. Soluble proteins 
were extracted by centrifuging the homogenised cells at 18,000 × g at 4 °C for 10 minutes. Protein concentration 
was estimated using BCA assay (Micro BCA Protein Assay Kit, Thermo Scientific USA 23235). Approximately 
5 µg of total proteins were resolved on 4–12% SDS-PAGE gels and γ-secretase components were detected by 
Western immunoblotting45. Well characterised primary antibodies were used; NT1 (1:5000, PS1 N-terminal, 
kindly provided by Professor Paul Fraser University of Toronto103); Ab14 (1:5000, PS1 N-terminal, kindly pro-
vided by Professor Sam Gandy Mt Saini Hospital, NY103), Nicastrin (1:1000, Sigma-Aldrich, USA N1660); PEN-2 
(1:1000, Sigma–Aldrich, USA P5622) and APH1aL (1:1000, Sigma–Aldrich, USA A9603). Other primary anti-
bodies used in this study were WO2 (1:5000, APP/Aβ, kindly provided by Professor Colin Masters University of 
Melbourne); 6E10 (1:1000, APP/Aβ, Covance USA 39300), penta-histidine antibody (1:1000, Qiagen, Germany 
34660) and Flag-M2-HRP (1:1000, Sigma–Aldrich, USA A8592). Immunoblots were developed using electro-
chemiluminescence reagent (Amersham ECL, GE, USA RPN2232; or BioRad, USA 1705061) and protein bands 
were detected using X-ray films (Amersham Hyperfilm ECL, GE, USA 28906835) or ChemiDoc XRS+ (BioRad).
Deglycosylation experiments. Human neuroblastoma SHSY5Y cells or PS1(wt)-γ-secretase infected Sf9 
cell lysates were prepared in Nonidet P-40 lysis buffer as mentioned above. Next, 5 µg of PS1(wt)-γ-secretase 
expressing insect cell lysate and 50 µg of SHSY5Y cell lysates were denatured and deglycosylated with either 
Endo-H (NEB P0702) or PNGase -F (NEB P0704) enzymes following manufacturer’s protocol.
Co- Immunoprecipitation studies. Co-Immunoprecipitation was carried out as described previ-
ously104,105. Infected insect cell membranes were dissolved in 1% CHAPSO-HEPES buffer (25 mM HEPES, pH7.4; 
150 mM NaCl; 1% CHAPSO w/v; Buffer A) and diluted to 1 mg/ml protein concentration, using the same buffer. 
Soluble membranes were incubated with PS1 antibody Ab14 (rabbit polyclonal raised against 1–25 amino acids of 
PS1) overnight at 4 °C under gentle agitation. Protein-A Mag Sepharose (GE, UK 28951378) was used to harvest 
protein antibody complexes and eluted in LDS sample buffer (Invitrogen, USA NP0007) at 37 °C for 15 minutes 
for SDS-PAGE and Western immunoblotting.
Preparation of cell membranes from Sf9 cells. Sf9 suspension cultures were infected with recombinant 
baculoviruses at MOI of 1 PFU. Following maximal protein expression (as monitored by YFP measurement), cells 
were collected by centrifugation at 300 × g for 5 minutes at room temperature. The cell pellet was homogenised 
in equal volume of homogenising buffer (5 mM Hepes pH 7.4; 250 mM Sucrose; 1 mM EDTA and cOmpleteTM 
protease inhibitor) and lysed by drawing in and out of a 26 gauge needle, ~15 times (for small 25–50 ml cultures) 
or freeze thawing cell suspension (for 500–1000 ml cultures). Cell and nuclear debris were removed by centrifu-
gation at 800 × g for 10 minutes at 4 °C. The supernatant was transferred to ultracentrifugation tubes and the cell 
membranes were pelleted by centrifugation at 100,000 × g for 60 minutes at 4 °C. The membrane pellet was stored 
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at −80 °C until required. The membrane pellet was resuspended in buffer A and homogenised using a 26-gauge 
needle, drawing in and out 15 times (for small 25–50 ml cultures) or 20 strokes of a Dounce homogeniser (for 
500–1000 ml cultures) on ice. The cell membranes were allowed to solubilise at 4 °C for 1 hour, using end over end 
rotation (10 rpm). Insoluble membranes were removed by centrifugation at 100,000 × g for 60 minutes at 4 °C and 
the supernatant containing dissolved membranes was used immediately.
Purification of reconstituted γ-secretase enzyme complex. PS1(wt)-γ-secretase infected Sf9 cell 
membranes (100 ml culture growing at 2 × 106 cells/ml) were prepared as mentioned above in 1% CHAPSO- 
HEPES buffer (Buffer A, containing cOmplete™, EDTA-free Protease Inhibitor Roche 11873580001; henceforth 
called buffer B). The membranes were then diluted to 0.08% CHAPSO and 0.08% Digitonin (from a 2% stock 
solution) using Buffer B. The sample was then incubated at 4 °C with end to end rotation of 10 rpm for 16 hours 
with 3 ml of His TALON, IMAC resin (GE, Sweden 28957502) pre-equilibrated with 0.08% CHAPSO and 0.08% 
Digitonin- Buffer B. The resin was collected into an empty PD10 column (GE, USA 17043501) and flowthrough 
was saved. The resin was then rinsed with 30 ml of buffer B to remove unbound proteins. Next, the resin was 
rinsed twice in 3 ml of 5 mM Imidazole in Buffer B, to remove any weekly bound proteins. Finally, γ-secretase was 
eluted in 3 ml fractions of 100 mM Imidazole in Buffer B.
Next, IMAC purified 100 mM Imidazole fractions were pooled and supplemented with 2 mM Calcium 
Chloride (CaCl2) and 2 mM Magnesium acetate (MgOAc). The pooled fractions were then incubated at 4 °C with 
end to end rotation of 10 rpm for 16 hours with 3 ml of Calmodulin affinity Resin (CaM) (GE, Sweden 17052901) 
equilibrated in buffer B supplemented with 2 mM CaCl2 and 2 mM Magnesium acetate (Buffer C). The resin was 
rinsed in 30 ml of Buffer C and eluted in 3 ml fractions of 0.5% CHAPSO in 25 mM Tris, 150 mM NaCl and 2 mM 
MgOAc (Buffer D) supplemented with 10 mM of EGTA. The 10 mM EGTA fractions were pooled and concen-
trated with a 50 kDa molecular weight cut-off centrifugal filter (50MWCO, GE USA 28932362). The IMAC and 
CaM purification fractions were resolved on a 4–20% SDS-PAGE and various components of γ-secretase enzyme 
complex were detected by Coomassie stain and Western immunoblotting.
Cell free γ-secretase assay. In vitro cell-free assays were performed using E. coli expressed APP-C99-Flag 
(N-terminal 99 amino acids of APP-CTF, starting with an additional methionine and a Flag tag at C-terminus) 
and Notch-C100-Flag (N-terminal 99 amino acids of NotchΔE, starting with an additional methionine and a 
Flag tag at C-terminus) as previously described54,55,106. Briefly, APP-C99-Flag and Notch-C100-Flag inserts were 
cloned into pET29 vector and transformed into BL21(DE3) E. coli cells (New England Biolabs) for substrate 
expression. Recombinant protein expression was induced using 1 mM IPTG following the manufacturer’s proto-
col. The cells were collected by centrifugation at 8000 × g for 10 minutes at 4 °C. Cell pellet was re-suspended in 
solubilising buffer (50 mM Tris-HCl pH8.0, 150 mM NaCl and cOmpleteTM protease inhibitor). The cell suspen-
sion was sonicated 6 times in an ice bath at 15% amplitude for 10 seconds, with intermittent cooling of 1 minute 
each. The homogenate was then supplemented with 1% Nonidet P-40 (v/v) detergent and incubated on ice for 
1 hour. Detergent soluble substrates were collected by centrifuging the homogenised cells at 20,000 × g for 10 min-
utes at 4 °C. The solubilised substrates were aliquoted and rapidly frozen in liquid nitrogen and stored at −80 °C.
Insect cell membranes dissolved in 1% CHAPSO-Hepes buffer were diluted to 0.5% CHAPSO with 150 mM 
Sodium citrate, (pH 6.4) and mixed with equal parts of cell free assay reaction buffer (150 mM Sodium Citrate 
(pH 6.4); 20 mM Dithiothreitol (DTT); 0.1% phosphatidylcholine (PC) lipid (Avanti Polar Lipids, USA 840053); 
0.025% phosphatidylethanolamine (PE) lipid (Avanti Polar Lipids, USA 840022); 0.2% BSA; 2 mM EDTA; cOm-
pleteTM protease inhibitor cocktail (Roche, 500 mg/ml) and 10 µl of substrate). Final detergent concentrations 
were 0.25% CHAPSO and <0.05% Nonidet P-40. Enzymatic reactions were carried out at 37 °C, for 16 hours and 
terminated by adding LDS gel loading sample buffer/freezing at −20 °C. Similarly, IMAC and CaM purification 
fractions were incubated with equal volumes of reaction buffer containing appropriate substrate. The reaction 
products were resolved by SDS-PAGE and immunoblotted to detect AICD/Aβ or NICD. Levels of Aβ40 and 
Aβ42 peptides generated in three different cell free assay experiments were quantified using ELISA kits (Life 
Technologies, Austria KHB3441 and KHB3481), following manufacturer’s protocols.
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